Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

Εμφάνιση άλλων εκδόσεων (1)

As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer of rituximab (Roche Products) to submit evidence of the clinical and cost effectiveness of rituximab in combination with corticosteroids for treatment of an...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Latimer, N, Carroll, C, Wong, R, Tappenden, P, Venning, M, Luqmani, R
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2014

Παρόμοια τεκμήρια

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
ανά: Latimer, N, κ.ά.
Έκδοση: (2014)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
ανά: Guerry, M, κ.ά.
Έκδοση: (2012)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
ανά: Flossmann, O, κ.ά.
Έκδοση: (2006)

Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis
ανά: Michael A Paley, κ.ά.
Έκδοση: (2019-01-01)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
ανά: Robson, J, κ.ά.
Έκδοση: (2017)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
ανά: Basu, N, κ.ά.
Έκδοση: (2014)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
ανά: Pearce, F, κ.ά.
Έκδοση: (2017)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
ανά: Thomas Hellmark, κ.ά.
Έκδοση: (2019-03-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis following rituximab: Outcomes of 50 patients in a tertiary single centre
ανά: Fahidah Alenzi, κ.ά.
Έκδοση: (2023-09-01)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
ανά: Valentina Binda, κ.ά.
Έκδοση: (2021-12-01)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
ανά: Alan D. Salama
Έκδοση: (2020-01-01)

Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
ανά: Cheng-Hua Weng, κ.ά.
Έκδοση: (2019-12-01)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
ανά: Robson, J, κ.ά.
Έκδοση: (2017)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
ανά: Saket Jha, κ.ά.
Έκδοση: (2019-01-01)

Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report
ανά: Xinyu Weng, κ.ά.
Έκδοση: (2022-03-01)

Cardiovascular and Cerebrovascular Outcomes in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
ανά: Shiyu Xiao, κ.ά.
Έκδοση: (2024-01-01)

Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
ανά: Christopher Maximilian Arends, κ.ά.
Έκδοση: (2020-06-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
ανά: Haiting Wu, κ.ά.
Έκδοση: (2022-04-01)

A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
ανά: Marta Casal Moura, κ.ά.
Έκδοση: (2022-11-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
ανά: Daisuke Tsukui, κ.ά.
Έκδοση: (2021-01-01)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
ανά: Hellmich, B, κ.ά.
Έκδοση: (2007)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
ανά: Laura S. van Dam, κ.ά.
Έκδοση: (2020-12-01)

Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
ανά: Luqmani, R, κ.ά.
Έκδοση: (2017)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
ανά: E. N. Vorkel, κ.ά.
Έκδοση: (2024-12-01)

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
ανά: Weijun Liu, κ.ά.
Έκδοση: (2024-05-01)

Recent advances in the diagnosis and treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
ανά: Si-wei Tang, κ.ά.
Έκδοση: (2024-03-01)

Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
ανά: Anders Esberg, κ.ά.
Έκδοση: (2022-08-01)

Late Onset of Rivaroxaban-Associated Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
ανά: Muskan Agarwal MD, κ.ά.
Έκδοση: (2023-10-01)

A case of Sjögren syndrome and anti-neutrophil cytoplasmic antibody-associated vasculitis
ανά: K. Kaynar, κ.ά.
Έκδοση: (2023-07-01)

Testicular granulomatous vasculitis mimicking testicular torsion in an anti-neutrophil cytoplasmic antibody–associated vasculitis patient
ανά: Liye Suo, κ.ά.
Έκδοση: (2019-01-01)

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic antibody associated vasculitis
ανά: Naidan Zhang, MS, κ.ά.
Έκδοση: (2022-06-01)

Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
ανά: Salomon R, κ.ά.
Έκδοση: (2011-09-01)

Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis
ανά: CM Wortel, κ.ά.
Έκδοση: (2025-02-01)

Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians
ανά: David Massicotte-Azarniouch, κ.ά.
Έκδοση: (2024-08-01)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
ανά: Mukhtyar, C, κ.ά.
Έκδοση: (2006)

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
ανά: Zhi-Ying Li, κ.ά.
Έκδοση: (2020-08-01)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
ανά: Moog P, κ.ά.
Έκδοση: (2015-11-01)

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
ανά: Despina Michailidou, κ.ά.
Έκδοση: (2022-06-01)

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
ανά: McLaren, J, κ.ά.
Έκδοση: (2001)

Anti-neutrophil cytoplasmic antibody–associated vasculitis complicated with diffuse alveolar haemorrhage and central nervous system vasculitis
ανά: Takashi Nawata, κ.ά.
Έκδοση: (2021-04-01)